Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials.

Cohen JA, Arnold DL, DeLuca J, Hartung HP, Kappos L, Comi G, Selmaj K, Steinman L, Bar-Or A, Montalban X, Havrdová EK, Sheffield JK, Pachai C, Cheng CY, Riolo JV, Cree BA

Open source

DOI
10.1177/13524585251355842
Published
2025 Sep
Container
Multiple sclerosis (Houndmills, Basingstoke, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/13524585251355842,
  title = {Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials.},
  author = {Cohen JA and Arnold DL and DeLuca J and Hartung HP and Kappos L and Comi G and Selmaj K and Steinman L and Bar-Or A and Montalban X and Havrdová EK and Sheffield JK and Pachai C and Cheng CY and Riolo JV and Cree BA},
  year = {2025},
  journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
  doi = {10.1177/13524585251355842},
  url = {https://doi.org/10.1177/13524585251355842}
}

RIS

TY  - JOUR
TI  - Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials.
AU  - Cohen JA
AU  - Arnold DL
AU  - DeLuca J
AU  - Hartung HP
AU  - Kappos L
AU  - Comi G
AU  - Selmaj K
AU  - Steinman L
AU  - Bar-Or A
AU  - Montalban X
AU  - Havrdová EK
AU  - Sheffield JK
AU  - Pachai C
AU  - Cheng CY
AU  - Riolo JV
AU  - Cree BA
PY  - 2025
JO  - Multiple sclerosis (Houndmills, Basingstoke, England)
DO  - 10.1177/13524585251355842
UR  - https://doi.org/10.1177/13524585251355842
ER  - 

APA

JA, C., DL, A., J, D., HP, H., L, K., G, C., K, S., L, S., A, B., X, M., EK, H., JK, S., C, P., CY, C., JV, R., & BA, C. (2025). Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials.. Multiple sclerosis (Houndmills, Basingstoke, England). https://doi.org/10.1177/13524585251355842

Source records